ArticleCellular & molecular immunology2019

A novel oncolytic virus engineered with PD-L1 scFv effectively inhibits tumor growth in a mouse model.

Chuanjian Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.